Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
JAMA Oncology
|
February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Jason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
Urologic Oncology
|
April 25, 2024
An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer
Jacob Knorr, Zaeem Lone, Glenn Werneburg, et al.
Urology Practice
|
August 22, 2025
Reply by Authors
Kieran Lewis, Jayant Siva, Angelica Bartholomew, et al.
Urologic Oncology
|
June 16, 2024
Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancer
Rebecca A Campbell, Andrew Wood, Patrick D Michael, et al.
BJU International
|
July 3, 2025
Degree of contrast enhancement improves prediction of new baseline glomerular filtration rate following radical nephrectomy
Jayant Siva, Anne Wong, Kieran Lewis, et al.
Clinical Genitourinary Cancer
|
March 27, 2018
Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function
Vadim S Koshkin, Pedro C Barata, Lisa A Rybicki, et al.
BJU International
|
April 18, 2021
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy
Nima Almassi, Emily A Vertosick, Daniel D Sjoberg, et al.
Urology Practice
|
May 5, 2025
A Split Renal Function-Based Approach for Predicting New Baseline Glomerular Filtration Rate After Radical Nephroureterectomy
Kieran Lewis, Jayant Siva, Angelica Bartholomew, et al.
Urologic Oncology
|
August 11, 2022
The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy
Zaeem Lone, Ao Zhang, Tarik Benidir, et al.
Urology
|
June 30, 2022
Comparing Pathologic and Survival Outcomes Between Primary and Secondary Muscle Invasive Bladder Cancer When Treated by Radical Cystectomy With or Without Neoadjuvant Chemotherapy
Tarik Benidir, Zaeem Lone, Ao Zhang, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
JAMA Oncology
|
February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Jason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
Urologic Oncology
|
April 25, 2024
An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer
Jacob Knorr, Zaeem Lone, Glenn Werneburg, et al.
Urology Practice
|
August 22, 2025
Reply by Authors
Kieran Lewis, Jayant Siva, Angelica Bartholomew, et al.
Urologic Oncology
|
June 16, 2024
Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancer
Rebecca A Campbell, Andrew Wood, Patrick D Michael, et al.
BJU International
|
July 3, 2025
Degree of contrast enhancement improves prediction of new baseline glomerular filtration rate following radical nephrectomy
Jayant Siva, Anne Wong, Kieran Lewis, et al.
Clinical Genitourinary Cancer
|
March 27, 2018
Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function
Vadim S Koshkin, Pedro C Barata, Lisa A Rybicki, et al.
BJU International
|
April 18, 2021
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy
Nima Almassi, Emily A Vertosick, Daniel D Sjoberg, et al.
Urology Practice
|
May 5, 2025
A Split Renal Function-Based Approach for Predicting New Baseline Glomerular Filtration Rate After Radical Nephroureterectomy
Kieran Lewis, Jayant Siva, Angelica Bartholomew, et al.
Urologic Oncology
|
August 11, 2022
The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy
Zaeem Lone, Ao Zhang, Tarik Benidir, et al.
Urology
|
June 30, 2022
Comparing Pathologic and Survival Outcomes Between Primary and Secondary Muscle Invasive Bladder Cancer When Treated by Radical Cystectomy With or Without Neoadjuvant Chemotherapy
Tarik Benidir, Zaeem Lone, Ao Zhang, et al.
Page
of 9